About
Obsidian Therapeutics, Inc. is a biotechnology company developing novel synthetic immunology therapies to precisely regulate immune responses for the treatment of autoimmune diseases and organ transplant rejection.
Explore Obsidian Therapeutics, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.